Lirafugratinib attenuates ABCG2-dependent drug efflux and restores chemosensitivity in multidrug-resistant nonsmall cell lung cancer cells. - Wu CP; Li YC; Lin BH; Murakami M; Chang YT; Wu YS; Hung TH; Ambudkar SV (Drug metabolism and disposition: the biological fate of chemicals, 2026)